CN Stock MarketDetailed Quotes

Realcan Pharmaceutical Group (002589)

Watchlist
  • 3.18
  • -0.07-2.15%
Market Closed Apr 30 15:00 CST
4.78BMarket Cap318.00P/E (TTM)

Realcan Pharmaceutical Group (002589) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Drug sales5.64B77.32%
器械销售1.49B20.36%
Sales of other products95.1M1.30%
移动医疗软件及服务销售45.75M0.63%
rent out28.56M0.39%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical instruments7.13B97.68%
Sales of other products95.1M1.30%
移动医疗软件及服务销售45.75M0.63%
rent out28.56M0.39%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Yantai city1.65B22.64%
Jinan city1.38B18.97%
Other1.15B15.71%
Qingdao city728.91M9.99%
Other693M9.50%
Weihai City551.64M7.56%
Binzhou City317.28M4.35%
Weifang city308.84M4.23%
Zibo city262.06M3.59%
Dongying city252.86M3.47%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More